Ars Pharmaceuticals Inc stock is traded at $3.56, with a volume of 2,684,383. It is up +13.02% in the last 24 hours and down -15.84% over the past month. ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the commercialization and development of neffy (currently identified in the European Union (EU) and United Kingdom (U.K.) by the trade name EURneffy and in China) for needle-free intranasal delivery of epinephrine for emergency treatment of Type I allergic reactions, including anaphylaxis. Neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows Neffy to safely provide intranasal delivery of epinephrine at a low dose within the exposures of approved injectable products across a range of dosing conditions.
Previous Close:
$3.15
Open:
$3.15
24h Volume:
2,684,383
Relative Volume:
1.01
Market Cap:
$357.88M
Revenue:
$98.99M
Net Income/Loss:
-$197.98M
P/E Ratio:
-
EPS:
-$2.00
Net Cash Flow:
-$175.32M
1W Performance:
+16.72%
1M Performance:
-15.84%
6M Performance:
-59.27%
1Y Performance:
-59.91%
1-Day Range:
$3.07$3.74
1-Week Range:
$2.44$3.74
52-Week Range:
$2.44$13.15
Ars Pharmaceuticals Inc Stock (SPRY) Company Profile
Name
Ars Pharmaceuticals IncSector
HealthcareIndustry
BiotechnologyPhone
858-771-9307Address
11682 EL CAMINO REAL, SUITE 300, SAN DIEGO, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS